These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 15712281

  • 1. Molecular clues into the pathogenesis of statin-mediated muscle toxicity.
    Baker SK.
    Muscle Nerve; 2005 May; 31(5):572-80. PubMed ID: 15712281
    [Abstract] [Full Text] [Related]

  • 2. Statins induce apoptosis in rat and human myotube cultures by inhibiting protein geranylgeranylation but not ubiquinone.
    Johnson TE, Zhang X, Bleicher KB, Dysart G, Loughlin AF, Schaefer WH, Umbenhauer DR.
    Toxicol Appl Pharmacol; 2004 Nov 01; 200(3):237-50. PubMed ID: 15504460
    [Abstract] [Full Text] [Related]

  • 3. Effect of simvastatin on cholesterol metabolism in C2C12 myotubes and HepG2 cells, and consequences for statin-induced myopathy.
    Mullen PJ, Lüscher B, Scharnagl H, Krähenbühl S, Brecht K.
    Biochem Pharmacol; 2010 Apr 15; 79(8):1200-9. PubMed ID: 20018177
    [Abstract] [Full Text] [Related]

  • 4. HMG-CoA reductase inhibitors and coenzyme Q10.
    Nawarskas JJ.
    Cardiol Rev; 2005 Apr 15; 13(2):76-9. PubMed ID: 15705257
    [Abstract] [Full Text] [Related]

  • 5. Protective effects of a squalene synthase inhibitor, lapaquistat acetate (TAK-475), on statin-induced myotoxicity in guinea pigs.
    Nishimoto T, Ishikawa E, Anayama H, Hamajyo H, Nagai H, Hirakata M, Tozawa R.
    Toxicol Appl Pharmacol; 2007 Aug 15; 223(1):39-45. PubMed ID: 17599378
    [Abstract] [Full Text] [Related]

  • 6. Coenzyme Q10 and statin-related myopathy.
    Drug Ther Bull; 2015 May 15; 53(5):54-6. PubMed ID: 25977402
    [Abstract] [Full Text] [Related]

  • 7. Statin-associated neuromyotoxicity.
    Baker SK, Tarnopolsky MA.
    Drugs Today (Barc); 2005 Apr 15; 41(4):267-93. PubMed ID: 16034491
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The role of mitochondria in statin-induced myopathy.
    Apostolopoulou M, Corsini A, Roden M.
    Eur J Clin Invest; 2015 Jul 15; 45(7):745-54. PubMed ID: 25991405
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Decreased ubiquinone availability and impaired mitochondrial cytochrome oxidase activity associated with statin treatment.
    Duncan AJ, Hargreaves IP, Damian MS, Land JM, Heales SJ.
    Toxicol Mech Methods; 2009 Jan 15; 19(1):44-50. PubMed ID: 19778232
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of prenyltransferase activity by statins in both liver and muscle cell lines is not causative of cytotoxicity.
    Gee RH, Spinks JN, Malia JM, Johnston JD, Plant NJ, Plant KE.
    Toxicology; 2015 Mar 02; 329():40-8. PubMed ID: 25578243
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Statin myopathy: an update.
    Christopher-Stine L.
    Curr Opin Rheumatol; 2006 Nov 02; 18(6):647-53. PubMed ID: 17053514
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Statin-induced myopathy: the two faces of Janus.
    Arora R, Liebo M, Maldonado F.
    J Cardiovasc Pharmacol Ther; 2006 Jun 02; 11(2):105-12. PubMed ID: 16891287
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.